Article Text
PDF
Abstract
Aim The objective of this study was to evaluate the satisfaction of paramedics and patients in the use of Penthrox in pain management.
Method The material was collected by using a questionnaire between Dec 2016-Dec 2017 in the Hospital District of South Ostrobothnia. Penthrox was given to 68 patients and the paramedics recorded both their own answers and those of the patients in the questionnaire.
Results The mean satisfaction of the paramedics in the use of Penthrox was 7.85 on a scale 1–10 with a standard deviation (SD) of 2.36 (n=61). A total of 40% of the respondents scored their satisfaction as 8–10. The mean satisfaction of the patients was 8.04 with SD of 2.52 (n=49) and 51% of the patients rated the satisfaction to be 8–10. At baseline, the average pain of 65 patients was 8.09 with SD of 1.45. The average pain at 10 min after dosing was 5.42 with SD of 2.45 (n=64). Pain estimated at 10 min after dosing, a statistically significant difference was observed between pain at baseline (p<0.001). Among the adverse effects, nausea occurred in one (1.47%) and haemodynamic problems in two (2.94%) patients (n=68).
Conclusion Based on this study, most of the paramedics and patients were satisfied with the use of Penthrox in the treatment of pain. Penthrox relieved pain in a statistically significant manner and among the adverse effects, the occurrence of nausea and haemodynamic problems was limited.
Conflict of interest None
Funding For the analysis and publication of the study results has been granted by Mundipharma Oy
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.